A phase II multicenter study of erbitux (cetuximab) in patients with metastatic colorectal carcinoma.
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2011
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 12 Dec 2008 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 05 Sep 2007 Status change from in progress to completed